North East and North Cumbria
ICS Formulary
 
back
1 Gastro-intestinal system
01-05-01 Aminosalicylates

Mesalazine
Formulary

First Choice

  • Octasa MR® (400mg e/c m/r tablets): approved as first choice 400mg e/c m/r preparation for all new patients. Patients receiving Asacol® and Mesren® should be switched to Octasa® when appropriate. 800mg & 1600mg e/c m/r tablets also approved for suitable patients - to reduce tablet burden.
  • Pentasa® (500mg & 1000mg m/r tablets).
  • Mezavant® XL (1.2g e/c m/r tablets).
  • Salofalk® (500mg, 1000mg, 1500mg & 3000mg m/r granules/sachet) - only to be used in patients with difficulty in swallowing.
Link  MSN/2024/028: Discontinuation of Asacol 400mg MR gastro-resistant tablets

Green View adult BNF  View SPC online  View childrens BNF
Balsalazide Sodium
Formulary

Alternatives


Green plus View adult BNF  View SPC online  View childrens BNF
Mesalazine Rectal Preparations
Formulary
  • 500mg & 1g suppositories
  • 1g in 100ml retention enema, 2g in 59ml enema
  • 1g foam enema

 


Green View adult BNF  View SPC online  View childrens BNF
Sulfasalazine
Formulary
Link  County Durham and Darlington - Sulfasalazine shared care guideline
Link  North of Tyne, Gateshead and North Cumbria - Monitoring of Immune Modifying Drugs (IMDs) in Stable Adult Patients (excluding post transplantation) in Primary and Secondary Care shared care guideline
Link  South Tyneside and Sunderland APC Shared Care Guideline - sulfasalazine
Link  Tees Valley Shared Care Guideline - sulfasalazine

Amber View adult BNF  View SPC online  View childrens BNF